Vyome Holdings, Inc. (HIND)
2.09
+0.06
(+2.96%)
USD |
NASDAQ |
Oct 09, 16:00
Vyome Holdings EPS Diluted (Quarterly) : -0.0977 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0977 |
| March 31, 2026 | -0.1439 |
| December 31, 2025 | -0.207 |
| September 30, 2025 | -3.057 |
| June 30, 2025 | -0.176 |
| March 31, 2025 | -4.189 |
| December 31, 2024 | -5.179 |
| September 30, 2024 | -1419.10 |
| June 30, 2024 | -3.668 |
| March 31, 2024 | -5.422 |
| December 31, 2023 | -4.199 |
| September 30, 2023 | -59.37 |
| June 30, 2023 | -62.35 |
| March 31, 2023 | -90.39 |
| December 31, 2022 | -2056.66 |
| September 30, 2022 | -156646.4 |
| June 30, 2022 | -141815.8 |
| March 31, 2022 | -126854.7 |
| December 31, 2021 | -576647.6 |
| September 30, 2021 | -4278.20 |
| Date | Value |
|---|---|
| June 30, 2021 | -1375.59 |
| March 31, 2021 | -359840.7 |
| December 31, 2020 | -1.896M |
| September 30, 2020 | -1.147M |
| June 30, 2020 | -453661.5 |
| March 31, 2020 | -5924.87 |
| December 31, 2019 | -5556.34 |
| September 30, 2019 | -5319.44 |
| June 30, 2019 | -21903.99 |
| March 31, 2019 | -31205.16 |
| December 31, 2018 | -33713.37 |
| September 30, 2018 | -30157.68 |
| June 30, 2018 | -49795.32 |
| March 31, 2018 | -62104.95 |
| December 31, 2017 | -52200.00 |
| September 30, 2017 | -47850.00 |
| June 30, 2017 | -40020.00 |
| March 31, 2017 | -40890.00 |
| December 31, 2016 | -44370.00 |
| September 30, 2016 | -475020.0 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cardiac Biotech Solutions, Inc. | -0.0008 |
| Anika Therapeutics, Inc. | 0.2412 |
| Enovis Corp. | -0.0207 |
| Edwards Lifesciences Corp. | 0.4188 |
| Perspective Therapeutics, Inc. | -0.222 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.7197M |
| Revenue (Quarterly) | 0.027M |
| Total Expenses (Quarterly) | 0.7125M |
| Enterprise Value | 8.062M |
| Gross Profit Margin (Quarterly) | 33.33% |
| Profit Margin (Quarterly) | -2.67K% |
| Earnings Yield | -167.8% |
| Normalized Earnings Yield | -74.20 |